Showing results (1-10 of 111) with videos related to
Sort By:
Pageof 12
Journal of Receptor and Signal Transduction Research|June 23, 2018
Molecular dynamics and quantum chemistry-based approaches to identify isoform selective HDAC2 inhibitor - a novel target to prevent Alzheimer's diseaseSanjay K Choubey, Jeyaraman JeyakanthanJournal of Structural Biology|June 15, 2015
Catalytic pathway, substrate binding and stability in SAICAR synthetase: A structure and molecular dynamics studyKavyashree Manjunath, Jeyaraman Jeyakanthan, Kanagaraj SekarMicrobial Pathogenesis|December 21, 2016
Computational identification of potent inhibitors for Streptomycin 3″-adenylyltransferase of Serratia marcescensDhamodharan Prabhu, Ramasamy Vidhyavathi, Jeyaraman JeyakanthanJournal of Biomolecular Structure & Dynamics|May 5, 2016
Binding mode exploration of LuxR-thiazolidinedione analogues, e-pharmacophore-based virtual screening in the designing of LuxR inhibitors and its biological evaluationSundaraj Rajamanikandan, Jeyaraman Jeyakanthan, Pappu SrinivasanJournal of Basic Microbiology|October 26, 2020
Targeting VEGFR2 protein by marine Streptomyces globosus VITLGK011-derived compound BECA: An in vitro and in silico analysisRavi Lokesh, Jeyaraman Jeyakanthan, Krishnan KannabiranApplied Biochemistry and Biotechnology|August 19, 2016
Molecular Docking, Molecular Dynamics Simulations, Computational Screening to Design Quorum Sensing Inhibitors Targeting LuxP of Vibrio harveyi and Its Biological EvaluationSundaraj Rajamanikandan, Jeyaraman Jeyakanthan, Pappu SrinivasanJournal of Receptor and Signal Transduction Research|January 23, 2016
Structural insights on identification of potential lead compounds targeting WbpP in Vibrio vulnificus through structure-based approachesDakshinamurthy Sasikala, Jeyaraman Jeyakanthan, Pappu SrinivasanComputational Biology and Chemistry|December 4, 2024
Unveiling novel type 1 inhibitors for targeting LIM kinase 2 (LIMK2) for cancer therapeutics: An integrative pharmacoinformatics approachNagarajan Hemavathy, Vetrivel Umashankar, Jeyaraman JeyakanthanMolecular Diversity|September 26, 2024
Repurposing FDA-approved drugs for combating tigecycline resistance in Acinetobacter baumannii: in silico screening against BaeR proteinKarthika Alagesan, Hemavathy Nagarajan, Jeyaraman JeyakanthanMicrobial Pathogenesis|December 13, 2016
Discovery of potent inhibitors targeting Vibrio harveyi LuxR through shape and e-pharmacophore based virtual screening and its biological evaluationSundaraj Rajamanikandan, Jeyaraman Jeyakanthan, Pappu SrinivasanPageof 12